BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16905580)

  • 1. Sulphate and osteoarthritis: decrease of serum sulphate levels by an additional 3-h fast and a 3-h glucose tolerance test after an overnight fast.
    Blinn CM; Biggee BA; McAlindon TE; Nuite M; Silbert JE
    Ann Rheum Dis; 2006 Sep; 65(9):1223-5. PubMed ID: 16905580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis.
    Biggee BA; Blinn CM; Nuite M; Silbert JE; McAlindon TE
    Ann Rheum Dis; 2007 Feb; 66(2):260-2. PubMed ID: 16818461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.
    Biggee BA; Blinn CM; McAlindon TE; Nuite M; Silbert JE
    Ann Rheum Dis; 2006 Feb; 65(2):222-6. PubMed ID: 16079170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting serum sulfate levels before and after development of osteoarthritis in participants of the veterans administration normative aging longitudinal study do not differ from levels in participants in whom osteoarthritis did not develop.
    Blinn CM; Dibbs ER; Hronowski LJ; Vokonas PS; Silbert JE
    Arthritis Rheum; 2005 Sep; 52(9):2808-13. PubMed ID: 16145675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported fasting status for glucose-tolerance testing compared with fasting status identified by total bile-acid concentrations.
    Sargazi M; Neithercut WD
    J Clin Pathol; 2011 May; 64(5):430-2. PubMed ID: 21421695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency.
    Burge MR; Hardy KJ; Schade DS
    J Clin Endocrinol Metab; 1993 May; 76(5):1192-8. PubMed ID: 8496310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of whole-body glycogen deposition after oral glucose in normal subjects. Influence of the nutritional status.
    Féry F; Plat L; Balasse EO
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2810-6. PubMed ID: 9709952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose lowering effect of verapamil in fasted man.
    Andersson DE; Röjdmark S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():160-3. PubMed ID: 6398256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers.
    Andersen B; Beck-Nielsen H; Højlund K
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):514-9. PubMed ID: 21521350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man.
    Clore JN; Helm ST; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1990 Apr; 70(4):865-8. PubMed ID: 2180979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum levels of glucosamine and sulphate after ingestion of glucosamine sulphate with and without simultaneous ingestion of glucose.
    Biggee BA; Blinn CM; Nuite M; McAlindon TE; Silbert JE
    Ann Rheum Dis; 2007 Oct; 66(10):1403-4. PubMed ID: 17881667
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged oral glucose tolerance test combined with indirect calorimetry and estimation of several substrates and hormones in obese subjects.
    Sonka J; Svacina S; Sucharda P; Hilgertová J; Kalvach Z; Límanová Z
    Acta Univ Carol Med (Praha); 1993; 39(1-4):39-47. PubMed ID: 9355660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1, 4GlcAbeta1,3GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.
    West LA; Roughley P; Nelson FR; Plaas AH
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):223-9. PubMed ID: 10432320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the glucose tolerance test in mice.
    Andrikopoulos S; Blair AR; Deluca N; Fam BC; Proietto J
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1323-32. PubMed ID: 18812462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.
    Succurro E; Marini MA; Grembiale A; Lugarà M; Andreozzi F; Sciacqua A; Hribal ML; Lauro R; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.